Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin for Ureteric Dilatation in RIRS
NCT05921370Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Apr 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in urolithiasis comparing Silodosin Group with Placebo Group (2 arms). Primary endpoint: Ureteric access sheath placement. Started Apr 2023; status: completed.
02
Drugs
silodosin
03
Conditions
urolithiasis
Beyond the preview
Go deeper on NCT05921370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05921370.